Showing 81 - 100 results of 2,816 for search '(( significant adverse decrease ) OR ( significant ((shape decrease) OR (small decrease)) ))', query time: 0.51s Refine Results
  1. 81

    Image 1_Cerebral small vessel disease as a possibly immune-related adverse event of immunotherapy in lung cancer patients: a retrospective study.tif by Na Wu (240778)

    Published 2025
    “…In the CSVD group, FT<sub>4</sub> levels decreased significantly between baseline and at the time of CSVD diagnosis, from 13.21 ± 4.56 pmol/L to 11.01 ± 2.11 pmol/L. …”
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90

    Baseline characteristics of the study population. by Hanbin Wu (14016246)

    Published 2025
    “…</p><p>Conclusion</p><p>Preconception hypoglycemia was significantly associated with adverse pregnancy outcomes, and maternal preconception BMI could modify the association. …”
  11. 91

    Achieving Improved Ion Swarm Shaping Based on Ion Leakage Control in Ion Mobility Spectrometry by Jiyao Wang (2121157)

    Published 2025
    “…In Ion Mobility Spectrometry (IMS), ion gates are essential for controlling ion flow, significantly impacting detection sensitivity and resolution. …”
  12. 92
  13. 93

    The incidence rate of adverse reactions. by Xuqin Du (8803772)

    Published 2025
    “…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98
  19. 99
  20. 100